PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 30, 20260 citationsOpen Access

Advancing the multivalent vaccine horizon: development of bicistronic self-amplifying RNA platforms for next-generation immunobiologicals

View Full Paper
TCThiago ChavesGVGiovanni VitaFMFernanda Moretão

Key Points

  • The aim is to evaluate new bicistronic self-amplifying RNA platforms for enhancing vaccine efficacy.
  • Development of bicistronic self-amplifying RNA platforms
  • Evaluation of immunobiological potential
  • Presentation at the International Symposium
  • Demonstrated advancements in multivalent vaccine technology
  • Highlighted the effectiveness of self-amplifying RNA in immunobiological applications

Abstract

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chaves et al. (2026) studied this question.

synapsesocial.com/papers/6a1a7dc00307b78509430c5ahttps://doi.org/10.35259/isi.2026_76354
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cellular immunological mechanisms induced by messenger RNA vaccine2026
  2. 2Development of targeted immunomodulatory VLPs to enhance antigen presentation and potentiate the antitumor immune response2026
  3. 3Bio-Manguinhos and new generation of vaccines: consolidation of mRNA-LNP production and evaluation of critical quality attributes at pilot scale2026
  4. 4Analytical technology transfer for mRNA vaccine quality control2026
  5. 5Evaluation of a stabilizing agent in messenger RNA vaccines for logistical application in Brazil2026